MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation
Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation
Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation
Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation
Journal Article

Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation

2018
Request Book From Autostore and Choose the Collection Method
Overview
Background Autophagy regulation through exogenous materials has aroused intensive attention to develop treatment protocols according to diverse human diseases. However, to the best of our knowledge, few examples have been reported to selectively control autophagy process and ultimately achieve efficient therapeutic potential. Results In this study, monolayers of poly (acryloyl- l , d and racemic valine) ( l -PAV-AuNPs, d -PAV-AuNPs and l / d -PAV-AuNPs) chiral molecules were anchored on the surfaces of gold nanoparticles (PAV-AuNPs), and the subsequent chirality-selective effects on autophagy activation were thoroughly studied. The cytotoxicity induced by PAV-AuNPs towards MDA-MB-231 cells (Breast cancer cells) was achieved mainly through autophagy and showed chirality-dependent, with d -PAV-AuNPs exhibiting high autophagy-inducing activity in vitro and in vivo. In contrast, the PAV-AuNPs exhibited autophagy inactivation for normal cells, e.g., 3T3 fibroblasts and HBL-100 cells. The chirality-selective autophagy activation effect in MDA-MB-231 cells was likely attributed to the chirality-variant ROS generation, cellular uptake and their continuous autophagy stimulus. Furthermore, the intratumoral injection of d -PAV-AuNPs could largely suppress the tumor growth but exhibit negligible toxicity in vivo. Conclusions As the first exploration on stereospecific NPs for autophagy induction, this work not only substantiates that chiral polymer coated NPs can selective induce autophagy-specific in cancer cells and achieve a high tumor eradication efficiency in vivo, but also opens up a new direction in discovering unprecedented stereospecific nanoagents for autophagy-associated tumor treatment.